PureTech Health plc
PureTech Health plc (LSE: PRTC) is trading at £1.14, about ₹145 at today's GBP/INR rate, as of 25 Sep 2026, 11:35 AM ET, down 1.38% today. Indian residents can buy PureTech Health from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
£1.14
Today's high
£1.17
52 week low
£1.07
52 week high
£1.44
PRTC opened at £1.16, closed previously at £1.16, and has traded between £1.07 and £1.44 over the past 52 weeks.
About
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.
Key statistics
Avg. volume
626.49K
Market cap
£278.47M
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
0.77
Dividend yield
—
Last dividend
£0.00
Financial overview
Revenue
$4.76M
Earnings per share
-$0.47
Free cash flow
-$86.92M
Net profit margin
—
Gross margin
—
EBITDA
-$97.17M
Revenue growth
10.24%
Similar securities
This is not an investment recommendation
How to buy PureTech Health from India
Indian residents can buy PureTech Health shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.
Search for PureTech Health and place an order
Find PureTech Health by name or by its ticker, PRTC, and choose an order type. PureTech Health trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your PureTech Health position in GBP and INR. PureTech Health pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in PureTech Health from India
Trading and taxes when buying PureTech Health from India
Trading and limits
- Trading hours
- 8:00 am – 4:30 pm UK
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePureTech Health does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Transaction tax
- The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy PureTech Health stock?
Yes. PureTech Health (PRTC) has been listed on the London Stock Exchange since 2015, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one PureTech Health share cost in rupees?
One PureTech Health share is £1.14 — about ₹145 at a GBP/INR rate of 126.99 on 26 Sep 2026. Both the PureTech Health price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying PureTech Health from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on PureTech Health shares taxed in India?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the PureTech Health price. Paasa issues a capital-gains statement for your return.
Does PureTech Health pay a dividend?
No. PureTech Health does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade PureTech Health from India?
The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.
Is PureTech Health a United Kingdom company, and does that change how it is taxed?
PureTech Health trades on the London Stock Exchange in GBP, but the company is domiciled in United States. PureTech Health trades as an ordinary share listed directly in the UK, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Are there transaction taxes when buying PureTech Health?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.
Do I have to declare PureTech Health shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your PureTech Health holding, its cost and its closing value.
How do I sell PureTech Health and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.